JPMorgan Chase & Co. Purchases 110,141 Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM)
JPMorgan Chase & Co. increased its position in Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Free Report) by 804.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 123,831 shares of the company’s stock after acquiring an additional 110,141 shares during the period. JPMorgan […]
JPMorgan Chase & Co. increased its position in Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Free Report) by 804.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 123,831 shares of the company’s stock after acquiring an additional 110,141 shares during the period. JPMorgan […]
